Tudor Investment Corp ET AL Buys Shares of 177,409 Phreesia, Inc. $PHR

Key Points

• Tudor Investment Corp ET AL acquired a new position of 177,409 shares of Phreesia (~$4.17M), representing about 0.29% of the company; institutional investors now own roughly 92.1% of the stock.
• Multiple analysts sharply cut targets (BMO and Needham to $14, Truist to $11), though the MarketBeat consensus remains a “Moderate Buy” with a $22 consensus target and mixed ratings (12 Buy, 6 Hold, 1 Sell).
• Phreesia missed Q1 EPS ($0.02 vs. $0.07 expected) despite revenue rising 15.9% to $127.07M, and the stock is trading down (~$8.08, down 7.7%) near its 12‑month low of $7.77.

Tudor Investment Corp ET AL acquired a new position in Phreesia, Inc. (NYSE:PHR - Free Report) during the 3rd quarter, according to the company in its most recent disclosure with the SEC. The fund acquired 177,409 shares of the company's stock, valued at approximately $4,173,000. Tudor Investment Corp ET AL owned about 0.29% of Phreesia at the end of the most recent reporting period.

Other hedge funds also recently made changes to their positions in the company. Federated Hermes Inc. acquired a new position in shares of Phreesia in the 3rd quarter worth approximately $32,000. Asset Management One Co. Ltd. acquired a new position in shares of Phreesia in the third quarter worth about $45,000. State of Alaska Department of Revenue acquired a new position in shares of Phreesia in the third quarter worth about $83,000. Anchor Investment Management LLC acquired a new position in shares of Phreesia in the third quarter worth about $118,000. Finally, Smartleaf Asset Management LLC boosted its holdings in shares of Phreesia by 129.0% in the third quarter. Smartleaf Asset Management LLC now owns 6,449 shares of the company's stock worth $152,000 after buying an additional 3,633 shares during the period. Institutional investors and hedge funds own 92.10% of the company's stock.

Analysts Set New Price Targets

PHR has been the subject of several recent analyst reports. BMO Capital Markets decreased their target price on shares of Phreesia from $32.00 to $14.00 and set an "outperform" rating for the company in a report on Tuesday, March 31st. Needham & Company LLC decreased their target price on shares of Phreesia from $35.00 to $14.00 and set a "buy" rating for the company in a report on Tuesday, March 31st. Truist Financial reiterated a "hold" rating and issued a $11.00 target price (down from $24.00) on shares of Phreesia in a report on Tuesday, March 31st. Zacks Research cut shares of Phreesia from a "strong-buy" rating to a "hold" rating in a report on Tuesday, January 6th. Finally, Citizens Jmp reiterated a "market perform" rating on shares of Phreesia in a report on Wednesday, April 1st. Twelve research analysts have rated the stock with a Buy rating, six have assigned a Hold rating and one has issued a Sell rating to the company's stock. According to MarketBeat.com, the company has an average rating of "Moderate Buy" and a consensus target price of $22.00.

Phreesia Trading Down 7.7%

NYSE:PHR opened at $8.08 on Friday. Phreesia, Inc. has a 12 month low of $7.77 and a 12 month high of $32.76. The company's 50 day moving average is $11.43 and its 200-day moving average is $16.92. The firm has a market cap of $490.94 million, a price-to-earnings ratio of 269.33 and a beta of 0.86. The company has a quick ratio of 1.53, a current ratio of 1.53 and a debt-to-equity ratio of 0.41.

Phreesia (NYSE:PHR - Get Free Report) last announced its earnings results on Monday, March 30th. The company reported $0.02 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $0.07 by ($0.05). The company had revenue of $127.07 million for the quarter, compared to the consensus estimate of $126.75 million. Phreesia had a return on equity of 3.23% and a net margin of 0.48%.The company's revenue was up 15.9% compared to the same quarter last year. During the same period last year, the firm posted ($0.11) EPS. Equities analysts anticipate that Phreesia, Inc. will post -1.1 EPS for the current year.

Insider Buying and Selling

In related news, CFO Balaji Gandhi sold 3,829 shares of the company's stock in a transaction dated Wednesday, March 25th. The shares were sold at an average price of $11.26, for a total transaction of $43,114.54. Following the transaction, the chief financial officer owned 146,740 shares in the company, valued at $1,652,292.40. This represents a 2.54% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. Also, SVP Amy Beth Vanduyn sold 2,202 shares of the firm's stock in a transaction dated Friday, January 16th. The shares were sold at an average price of $16.36, for a total transaction of $36,024.72. Following the completion of the sale, the senior vice president owned 157,349 shares of the company's stock, valued at $2,574,229.64. The trade was a 1.38% decrease in their position. The SEC filing for this sale provides additional information. Insiders have sold 40,367 shares of company stock worth $613,251 in the last three months. Company insiders own 5.50% of the company's stock.

Phreesia Company Profile

Phreesia, Inc NYSE: PHR is a provider of patient intake management solutions designed to streamline front-office workflows for healthcare organizations. The company's cloud-based platform digitizes patient registration, appointment scheduling, insurance verification, consent documentation and payment collection through touchscreen kiosks, tablets and mobile devices. By replacing paper forms and manual processes, Phreesia enhances data accuracy, reduces administrative burden and improves the patient experience.

Founded in 2000 by Chaim Indig and headquartered in Burlington, Massachusetts, Phreesia offers a modular software suite that integrates with electronic medical record (EMR) and practice management systems.

Want to see what other hedge funds are holding PHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Phreesia, Inc. (NYSE:PHR - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.